Structure Therapeutics Inc. (GPCR) Tops Q3 EPS by 1c

Structure Therapeutics Inc. (NASDAQ: GPCR) reported Q3 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Structure Therapeutics Inc. (GPCR) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Shake Shack (SHAK) PT Lowered to $66 at Piper Sandler
• Fastenal (FAST) Reports In-Line Q2 EPS, Beats on Revenue